SentinHealth

SentinHealth operated as a medical technology firm, focusing on integrated care solutions for monitoring and preventing the worsening of heart failure. Founded in 2017 by Jean Marc Bourez and Marc Lemaire, the company was headquartered in Paris with a research lab in Grenoble. The firm's primary offering was a technology platform designed to monitor daily heart activity and other early warning signs of acute decompensated heart failure (ADHF) originating from the digestive tract. This system aimed to enable early detection of ADHF before hospitalization became necessary, thereby providing a crucial window for intervention for heart failure patients.

The core of SentinHealth's product was an AI-based monitoring platform that utilized a subcutaneous implant to gather regular and actionable data. This approach was intended to support healthcare providers, specifically hospitals, by offering a remote follow-up system for their patients. By providing continuous monitoring, the service sought to improve patients' quality of life, reduce mortality and morbidity, and lessen the significant economic impact of heart failure-related hospitalizations. The business model appeared to be centered on a Health-as-a-Service concept, targeting an active patient base.

Throughout its operation, SentinHealth secured angel funding on multiple occasions, including rounds in January 2018, December 2019, and January 2021, with Doliam listed as an institutional investor. The company achieved ISO 13485 certification in 2022, a standard for medical device quality management systems. Despite these milestones and plans for a Series A fundraising round in 2023 and regulatory submissions in the US and Europe, the company entered into liquidation proceedings in July 2023.

Keywords: heart failure monitoring, MedTech, integrated care, remote patient monitoring, AI in healthcare, subcutaneous implant, acute decompensated heart failure, ADHF detection, medical device, Health-as-a-Service, preventive cardiology, cardiovascular health, digital health, Jean Marc Bourez, Marc Lemaire, Paris MedTech, Grenoble research, hospital monitoring platform, cardiac monitoring, ISO 13485